Diagnosis and management of gastro-oesophageal reflux in preterm infants in neonatal intensive care units

Acta Paediatrica, International Journal of Paediatrics

Volumn 93, Issue 1, 2004, Pages 88-93

  Dhillon, A S ^a   Ewer, A K ^a  

^a BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

Author keywords

Gastro oesophageal reflux; Preterm infants

Indexed keywords

ANTACID AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROKINETIC AGENT; PROTON PUMP INHIBITOR;

ARTICLE; BODY POSITION; CLINICAL FEATURE; CONSULTATION; DEVICE; EVIDENCE BASED MEDICINE; GASTROESOPHAGEAL REFLUX; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; NEWBORN; PREMATURITY; PRIORITY JOURNAL; QUESTIONNAIRE; STANDARD; STOMACH PH;

ANTACIDS; FEMALE; GASTROESOPHAGEAL REFLUX; GESTATIONAL AGE; GREAT BRITAIN; HISTAMINE H2 ANTAGONISTS; HUMANS; INFANT FOOD; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE UNITS, NEONATAL; MALE; POSTURE; QUESTIONNAIRES;

EID: 1642537688     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/08035250310007934     Document Type: Article

References (51)

1. Newell SJ, Booth IW, Morgan MEI, Durbin GM, McNeish AS. Gastro-oesophageal reflux in preterm infants. Arch Dis Child 1989; 64: 780-6
2. Ewer AK, Durbin GM, Morgan MEI, Booth IW. Gastric emptying and gastro-oesophageal reflux in preterm infants. Arch Dis Child 1996; 75: F117-F21
3. Ng SCY, Quak SH. Gastroesophageal reflux in preterm infants: norms for extended distal esophageal pH monitoring. J Pediatr Gastroenterol Nutr 1998; 27: 411-4
4. Herbst JJ. Gastroesophageal reflux. J Pediatr 1981; 98: 859-70
5. Weihrauch TR. Gastro-oesophageal reflux - pathogenesis and clinical implications. Eur J Pediatr 1985; 144: 215-8
6. Hrabovsky EE, Mullett MD. Gastroesophageal reflux and the premature infant. J Pediatr Surg 1986; 21: 583-7
7. Jeffery HE, Page M. Developmental maturation of gastrooesophageal reflux in preterm infants. Acta Pædiatr 1995; 84: 245-50
8. Ewer AK, James ME, Tobin JM. Prone and left lateral positioning reduces gastro-oesophageal reflux in preterm infants. Arch Dis Child 1999; 81: F201-F5
9. James ME, Ewer AK. Acid oro-pharyngeal secretions can predict gastro-oesophageal reflux in preterm infants. Eur J Pediatr 1999; 158: 371-4
10. Grant L, Cochran D. Can pH monitoring reliably detect gastrooesophageal reflux in preterm infants? Arch Dis Child 2001; 85: F155-F8
11. St Cyr JA, Ferrara TB, Thompson TR, Johnson DE, Foker JE. Nissen fundoplication for gastroesophageal reflux in infants. J Thorac Cardiovasc Surg 1986; 92: 661-6
12. Giuffre RM, Rubin S, Mitchell I. Antireflux surgery in infants with bronchopulmonary dysplasia. Am J Dis Child 1987; 141: 648-51
13. Justo RN, Gray PH. Fundoplication in preterm infants with gastro-oesophageal reflux. J Paediatr Child Health 1991; 27: 250-4
14. Kimball AL, Carlton DP. Gastroesophageal reflux medications in the treatment of apnea in premature infants. J Pediatr 2001; 138: 355-60
15. Committee on Safety of Medicines and Medicines Control Agency. Cisapride (Prepulsid): risk of arrhythmias. Curr Probl Pharmacovigil 1998; 24: 11-4
16. Jolley SG, Johnson DG, Herbst JJ, Pena RA, Garnier CR. An assessment of gastroesophageal reflux in children by extended pH monitoring of the distal esophagus. Surgery 1978; 84: 16-24
17. Boix-Ochoa J, Lafuente JM, Gil-Vernet JM. Twenty-four hour esophageal pH monitoring in gastroesophageal reflux. J Pediatr Surg 1980; 15: 74-8
18. Sondheimer JM. Continuous monitoring of distal esophageal pH: a diagnostic test for gastroesophageal reflux in infants. J Pediatr 1980; 96: 804-7
19. Euler AR, Byrne WJ. Twenty-four hour esophageal intraluminal pH probe testing: a comparative analysis. Gastroenterology 1981; 80: 957-61
20. Vandenplas Y, Sacre-Smits L. Continuous 24-hour esophageal pH monitoring in 285 asymptomatic infants 0-15 months old. J Pediatr Gastroenterol Nutr 1987; 6: 220-4
21. Dalt LDA, Mazzoleni S, Montini G, Donzelli F, Zacchello F. Diagnostic accuracy of pH monitoring in gastro-oesophageal reflux. Arch Dis Child 1989; 64: 1421-6
22. Vandenplas Y, Loeb H. The interpretation of oesophageal pH monitoring data. Eur J Pediatr 1990; 149: 598-602
23. Vandenplas Y, Helven R, Goyvaerts H, Sacre L. Reproducibility of continuous 24 hour oesophageal pH monitoring in infants and children. Gut 1990; 31: 374-7
24. Graff MA, Kashlan F, Carter M, Rovell K, Ramos DG. Nap studies underestimate the incidence of gastroesophageal reflux. Pediatr Pulmonol 1994; 18: 258-60
25. Vandenplas Y, Belli D, Boige N, Bouquet J, Cadranel S, Cezard JP, et al. Society statement of the working group of the European Society of Pediatric Gastroenterology and Nutrition. A standardized protocol for the methodology of esophageal pH monitoring and interpretation of the data for the diagnosis of gastroesophageal reflux. J Pediatr Gastroenterol Nutr 1992; 14: 467-71
26. Bergmeijer JHLJ, Bouquet J, Hazebroek FWJ. Normal ranges of 24-hour pH-metry established in corrected esophageal atresia. J Pediatr Gastroenterol Nutr 1999; 28: 162-3
27. Vandenplas Y, Goyvaerts H, Helven R, Sacre L. Gastroesophageal reflux, as measured by 24-hour pH monitoring, in 509 healthy infants screened for risk of sudden infant death syndrome. Pediatrics 1991; 88: 834-40
28. Wenzl TG, Moroder C, Trachterna M, Thomson M, Silny J, Heimann G, et al. Esophageal pH monitoring and impedance measurement: a comparison of two diagnostic tests for gastroesophageal reflux. J Pediatr Gastroenterol Nutr 2002; 34: 519-23
29. Washington N, Spensley PJ, Smith CA, Parker M, Bush D, Jackson SJ, et al. Dual pH probe monitoring versus single pH probe monitoring in infants on milk feeds: the impact on diagnosis. Arch Dis Child 1999; 81: 309-12
30. Mitchell DJ, McClure BG, Tubman TRJ. Simultaneous monitoring of gastric and oesophageal pH reveals limitations of conventional oesophageal pH monitoring in milk fed infants. Arch Dis Child 2001; 84: 273-6
31. Badriul H, Vandemaele K, Vandenplas Y. Esophageal pH monitoring in infants: elimination of gastric buffering does not modify reflux index. J Pediatr Gastroenterol Nutr 1999; 29: 627
32. Hegar B, Vandemaele K, Arana A, Vandenplas Y. Oesophageal pH monitoring in infants: elimination of gastric buffering does not modify reflux index. J Gastroenterol Hepatol 2000; 15: 902-5
33. Wenzl TG. Investigating esophageal reflux with the intraluminal impedance technique. J Pediatr Gastroenterol Nutr 2002; 34: 261-8
34. Wenzl TG, Schneider S, Scheele F, Silny J, Heimann G, Skopnik H. Effects of thickened feeding on gastroesophageal reflux in infants: a placebo-controlled crossover study using intraluminal impedance. Pediatrics 2003; 111: e355-e9
35. Tobin JM, McCloud P, Cameron DJS. Posture and gastrooesophageal reflux: a case for left lateral positioning. Arch Dis Child 1997; 6: 254-8
36. Mitchell EA, Tuohy PG, Brunt JM, Thompson JMD, Clements MS, Stewart AW, et al. Risk factors for sudden infant death syndrome following the prevention campaign in New Zealand. Pediatrics 1997; 100: 835-40
37. Vandenplas Y, Hachimi-Idrissi S, Casteels A, Mahler T, Loeb H. A clinical trial with an "anti-regurgitation" formula. Eur J Pediatr 1994; 153: 419-23
38. Orenstein SR, Magill HL, Brooks P. Thickening of infant feedings for therapy of gastroesophageal reflux. J Pediatr 1987; 110: 181-6
39. Buts JP, Barudi C, Otte JB. Double-blind controlled study on the efficacy of sodium alginate (Gaviscon) in reducing gastroesophageal reflux assessed by 24 h continuous pH monitoring in infants and children. Eur J Pediatr 1987; 146: 156-8
40. Bailey DJ, Andres JM, Danek GS, Pineiro-Carrero VM. Lack of efficacy of thickened feeding as treatment for gastroesophageal reflux. J Pediatr 1987; 110: 187-9
41. Forbes D, Hodgson M, Hill R. The effects of Gaviscon and Metoclopramide in gastroesophageal reflux in children. J Pediatr Gastroenterol Nutr 1986; 5: 556-9
42. Kelly EJ, Chatfield SL, Brownlee KG, Ng PC, Newell SJ, Dear PRF, et al. The effect of intravenous ranitidine on the intragastric pH of preterm infants receiving dexamethasone. Arch Dis Child 1993; 69: 37-9
43. 2-receptor antagonists have a therapeutic role in childhood? J Pediatr Gastroenterol Nutr 1994; 19: 270-6
44. DeLoore I, van Ravensteyn H, Ameryckx L. Domperidone drops in the symptomatic treatment of chronic paediatric vomiting and regurgitation. A comparison with metoclopramide. Postgrad Med J 1979; 55 Suppl 1: 40-2
45. Carroccio A, Iacono G, Montalto G, Cavataio F, Soresi M, Notarbartolo A. Domperidone plus magnesium hydroxide and aluminium hydroxide: a valid therapy in children with gastroesophageal reflux. Scand J Gastroenterol 1994; 29: 300-4
46. Mazur LJ, Baker RD, Boyle JT, Colletti RD, Gerson WT, Liptak GS, et al. Gastroesophageal reflux. In: Moyer VA, editor. Evidence based pediatrics and child health. London: Br Med J Publishing group 2000: 248-63
47. Bines JE, Quinlan JE, Treves S, Kleinman RE, Winter HS. Efficacy of domperidone in infants and children with gastroesophageal reflux. J Pediatr Gastroenterol Nutr 1992; 14: 400-5
48. Tolia V, Calhoun J, Kuhns L, Kauffman RE. Randomized, prospective double-blind trial of metoclopramide and placebo for gastroesophageal reflux in infants. J Pediatr 1989; 115: 141-5
49. Augood C, MacLennan S, Gilbert R, Logan S. Cisapride treatment for gastro-oesophageal reflux in children (Cochrane Review). In: The Cochrane Library. Issue 2, 2002; Oxford: Update Software
50. Bourke B, Drumm B. Cochrane's epitaph for cisapride in childhood gastro-oesophageal reflux. Arch Dis Child 2002; 86: 71-2
51. Committee on Safety of Medicines and Medicines Control Agency. Cisapride (Prepulsid) withdrawn. Curr Probl Pharmacovigil 2000; 26: 9-14